Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer

Title
Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer
Authors
Keywords
-
Journal
Clinical Breast Cancer
Volume 11, Issue 5, Pages 275-282
Publisher
Elsevier BV
Online
2011-05-23
DOI
10.1016/j.clbc.2011.03.018

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started